Related Experiment Video
Updated: Aug 5, 2026

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
Published on: September 2, 2025
Mapping stakeholders for developing cancer research in Small Island Developing States: a descriptive study from the
Stephen B Johnson1, Tricia Black2, Boris Atabe1
1Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, Québec, Canada.
This study mapped cancer control stakeholders in the Eastern Caribbean, finding low overall interest but strong advocacy from support groups and policymakers. These insights aim to build political will for vital cancer research in Small Island Developing States.
Area of Science:
- Public Health
- Epidemiology
- Health Policy
Background:
- High cancer mortality in Small Island Developing States (SIDS) is exacerbated by a lack of local epidemiological data.
- Effective stakeholder engagement is crucial for advancing cancer research and control initiatives in SIDS.
- The Cancer in Small Island Developing States of the Eastern Caribbean (CaSIDEC) study aims to address these gaps.
Purpose of the Study:
- To map cancer control stakeholders within the Organisation of Eastern Caribbean States (OECS) for the CaSIDEC study.
- To assess stakeholder power and interest to inform engagement strategies.
- To categorize stakeholders based on their potential influence and involvement in cancer research.
Main Methods:
- Stakeholders were identified through professional networks, snowballing, and public directories.
- Power and interest were scored based on available information and past interactions.
- Stakeholders were categorized into engagement typologies (promoters, latent, advocates, bystanders) and analyzed using descriptive statistics, with country-specific variations examined.
Main Results:
- Of 159 identified stakeholders, 96 were analyzed, comprising supporters (36%), policymakers (32%), implementers (18%), and civil society leaders (14%).
- Overall mean scores for interest (4.5/10) and power (4.7/10) were low.
- Stakeholders were distributed across typologies: latent (29%), bystanders (28%), advocates (23%), and promoters (20%), with implementers and policymakers forming the majority of promoters. Significant country-level variations in policymaker and implementer representation were observed.
Conclusions:
- This is the first stakeholder mapping for an epidemiological study in the Caribbean, revealing low interest in large-scale epidemiological research, similar to other developing regions.
- Cancer support groups and implementers emerged as key advocates for this research.
- Findings provide a foundation for strategies to enhance political will, generate new knowledge, and inform cancer control policy in SIDS.
Related Concept Videos
Cancer Survival Analysis
Mutagenicity and Carcinogenicity

